| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 745591 | Null | 0.00295310816022625 | 0.17981529 |
| NSC 747558 | 6-(4-Ethylphenyl)-2-benzenesulfonamidepyridazine-3(2H)-one | 0.00295310816022625 | 0.00018577595 |
| NSC 756170 | GSK317315A | 0.00295310816022625 | -0.12647151 |
| NSC 83492 | Null | 0.00295310816022625 | -0.040631292 |
| NSC 676792 | Olean-12-en-28-oic acid, 3-.beta.-(6-methyl-.beta.-D-glucopyranuronosyloxy)-, [2-O-[4-O-(.beta.-D-xylopyranosyl)-6-deoxy- .beta.-D-gulopyranosyl)]-.beta.-D-xylopyranosyl] ester | 0.00356954838698631 | 0.72849882 |
| NSC 625498 | 4-Morpholinecarbodithioic acid, antimony complex | 0.00359493104490023 | -0.074473553 |
| NSC 633963 | N,N'-Di{1-methyl-2-[1-methyl-2-carboxamido(3-propionamidine) -4-pyrrole]-4-pyrrolyl}suberamide dihydrochloride | 0.00366577979610622 | 0.2453357 |
| NSC 683833 | Null | 0.00366577979610627 | -0.24237954 |
| NSC 693867 | Null | 0.00366577979610627 | -0.28182551 |
| NSC 623599 | 4-Methyl-1,2,4-benzotriazin-3(4H)-imine 1-oxide, hydrochloride | 0.00374367388796147 | 0.14512069 |